Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictable modulation of cancer treatment outcomes by the gut microbiota.

Microbiome - 5 Mar 2020

Heshiki Yoshitaro, Vazquez-Uribe Ruben, Li Jin, Ni Yueqiong, Quainoo Scott, Imamovic Lejla, Li Jun, Sørensen Maria, Chow Billy K C, Weiss Glen J, Xu Aimin, Sommer Morten O A, Panagiotou Gianni

Abstract excerpt

The gut microbiota has the potential to influence the efficacy of cancer therapy. Here, we investigated the contribution of the intestinal microbiome on treatment outcomes in a heterogeneous cohort that included multiple cancer types to identify microbes with a global impact on immune response. Human gut metagenomic analysis revealed that responder patients had significantly higher microbial diversity and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacteria
Share to Feces

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gastrointestinal Microbiome

Share to Longitudinal Studies

Share to Lung Neoplasms

Share to Metagenomics

Share to Neoplasms

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 32138779
DOI: 10.1186/s40168-020-00811-2
PMCID: PMC7059390

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictable modulation of cancer treatment outcomes by the gut microbiota.PMID 32138779Read ↗

Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic targetSemantic proximity Read ↗

Gut microbiota as a biomarker and modulator of anti-tumor immunotherapy outcomesSemantic proximity Read ↗

Catalog of gut microbiota alterations associated with anticancer therapies across multiple cancer typesSemantic proximity Read ↗

Complex interactions between the microbiome and cancer immune therapySemantic proximity Read ↗

The gut microbiome: what the oncologist ought to knowSemantic proximity Read ↗

Interaction of bacterial genera associated with therapeutic response to immune checkpoint PD-1 blockade in a United States cohortSemantic proximity Read ↗

Predicting cancer immunotherapy response from gut microbiomes using machine learning modelsSemantic proximity Read ↗

Microbiota as diagnostic biomarkers: advancing early cancer detection and personalized therapeutic approaches through microbiome profilingSemantic proximity Read ↗

Comprehensive analysis of microbiota signature across 32 cancer typesSemantic proximity Read ↗

Gut microbiome metabolites, molecular mimicry, and species-level variation drive long-term efficacy and adverse event outcomes in lung cancer survivorsSemantic proximity Read ↗

Gut microbial signature in lung cancer patients highlights specific taxa as predictors for durable clinical benefitSemantic proximity Read ↗

Gut microbiota diversity and specific composition during immunotherapy in responders with non-small cell lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.